Hr low-positive/her2-negative breast neoplasms Clinical Trials

Delta Trials tracks 1 clinical trial for Hr low-positive/her2-negative breast neoplasms in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 0 trials have reached completion. This research is carried out at 232 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.